3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Myelodysplastic Syndromes
3
Leukemia, Myeloid, Acute
3
Glioblastoma
3
Brain Neoplasms
3
Glioma
2
Thyroid Neoplasms
1
Prostatic Neoplasms
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Precancerous Conditions
1
Neurologic Manifestations
1
Neoplasms, Neuroepithelial
1
Neoplasm Metastasis
1
Lymphoma
1
Leukemia
1
Head and Neck Neoplasms
1
HTLV-I Infections
1
Gliosarcoma
1
Diffuse Intrinsic Pontine Glioma
1
Breast Neoplasms
1
Astrocytoma
1
Interventions
Pemetrexed
12
Cisplatin
11
pembrolizumab
8
Carboplatin
6
Ipilimumab
5
Nivolumab
4
LMB-100
4
durvalumab
3
Gemcitabine
3
tremelimumab
2
tazemetostat
2
anetumab ravtansine
2
Vinorelbine
2
Plicamycin
2
Dexamethasone
2
Cyclophosphamide
2
Bevacizumab
2
vandetanib
1
tocilizumab
1
spartalizumab
1
ribociclib
1
rebastinib
1
pevonedistat
1
olaparib
1
niraparib
1
nintedanib
1
fludarabine phosphate
1
fludarabine
1
epacadostat
1
enzalutamide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Mesothelioma
×
Valproic Acid
×
Clear all
No trials found.